FY-2020 Top 20 Commercially Successful Inventions
| VACCINES & THERAPEUTICS |
Rank | | | |
1 | Nutritional Supplement to Treat Macular Degeneration | Ferris, et al. | NEI |
2 | Novel Protease Inhibitor for Treatment of Drug-Resistant HIV-1 | Erickson, et al. | NCI |
3 | Proteosome Inhibitor for Treatment of Multiple Myeloma | Gupta, et al. | NCI |
4 | Multivalent Human-Bovine Rotavirus Vaccine | Kapikian, et al. | NIAID |
6 | Pox Virus Based Veterinary Vaccines | Moss, et al. | NIAID |
8 | Palifermin for Treatment of Oral Mucositis | Rubin, et al. | NCI |
10 | Ulipristal Acetate Treatment of Uterine Fibroids | Nieman, et al. | NICHD |
17 | Dengue Virus Vaccine | Whitehead, et al. | NIAID |
| |
| DIAGNOSTICS |
Rank | | | |
5 | HIV-1 Diagnostic Test Kits | Gallo, et al. | NCI |
6 | DNA Probe for Breast Cancer Diagnosis (HER-2) | King, et al. | NCI |
9 | HIV-1 Genotyping Assays | Medabalimi, et al. | NCI |
14 | Norwalk-like Virus ELISA Assay | Green, et al. | NIAID |
| | | |
| INSTRUMENTATION & DEVICES |
Rank | | | |
12 | Transcranial Magnetic Stimulation System | Zangen, et al. | NIDA |
| | | |
| RESEARCH MATERIALS |
Rank | | | |
7 | Murine Colon 38 Cell Line | Hollingshead, et al. | NCI |
11 | Human Mast Cell Line LAD2 | Kirshenbaum, et al. | NIAID |
12 | Cell Lines Established from Certain Human Tumors | Oie, et al. | NCI |
13 | GMP-Qualified 293 Cell Line | Schwartz, et al. | NCI |
15 | Pan02 Cell Line | Hollingshead, et al. | NCI |
16 | RAAV-Binding Antibody | Smith, et al. | NHLBI |
18 | GL-7 Hybridoma Cell Line | Hodes, et al. | NCI |
19 | Human Multi-Drug Resistance Clone | Gottesman, et al. | NCI |
20 | Ovarian Tumor Antigen | Hamilton, et al. | NCI |